Adaptive Biotechnologies Corp Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Adaptive Biotechnologies Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Adaptive Biotechnologies Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$32.1M, a 36.2% increase year-over-year.
  • Adaptive Biotechnologies Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$195M, a 0.36% increase year-over-year.
  • Adaptive Biotechnologies Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$225M, a 12.5% decline from 2022.
  • Adaptive Biotechnologies Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$200M, a 3.42% increase from 2021.
  • Adaptive Biotechnologies Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$207M, a 41.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$225M -$25.1M -12.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$200M +$7.09M +3.42% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$207M -$61.1M -41.8% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$146M -$77.6M -113% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-14
2019 -$68.6M -$22.2M -47.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 -$46.4M -$3.62M -8.44% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 -$42.8M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.